Results 11 to 20 of about 2,298,895 (410)

Reduced humoral response to mRNA SARS-CoV-2 BNT162b2 vaccine in kidney transplant recipients without prior exposure to the virus

open access: yesAmerican Journal of Transplantation, 2021
COVID‐19 is associated with increased morbidity and mortality in transplant recipients. There are no efficacy data available regarding these patients with any of the available SARS‐CoV‐2 vaccines.
A. Grupper   +14 more
semanticscholar   +1 more source

Humoral Response after SARS-CoV-2 mRNA Vaccination in a Cohort of Hemodialysis Patients and Kidney Transplant Recipients

open access: yesJournal of the American Society of Nephrology, 2021
Visual Abstract Significance Statement Data are lacking on the humoral response to COVID-19 vaccination in kidney transplant recipients and patients on hemodialysis. This study of humoral response to an mRNA vaccine in 78 patients undergoing hemodialysis,
Clément Danthu   +14 more
semanticscholar   +1 more source

The RECOVAC Immune-response Study: The Immunogenicity, Tolerability, and Safety of COVID-19 Vaccination in Patients With Chronic Kidney Disease, on Dialysis, or Living With a Kidney Transplant

open access: yesTransplantation, 2021
Background. In kidney patients COVID-19 is associated with severely increased morbidity and mortality. A comprehensive comparison of the immunogenicity, tolerability, and safety of COVID-19 vaccination in different cohorts of kidney patients and a ...
J. Sanders   +25 more
semanticscholar   +1 more source

Social Determinants of Health and Race Disparities in Kidney Transplant.

open access: yesAmerican Society of Nephrology. Clinical Journal, 2021
BACKGROUND AND OBJECTIVES Black patients have a higher incidence of kidney failure but lower rate of deceased- and living-donor kidney transplantation compared with White patients, even after taking differences in comorbidities into account.
Hannah M. Wesselman   +12 more
semanticscholar   +1 more source

COVID-19 vaccination in kidney transplant recipients

open access: yesNature Reviews Nephrology, 2021
Kidney transplant recipients receive therapeutic immunosuppression that impairs their immune responses to the COVID-19 mRNA vaccine. For this reason, this vulnerable patient population is insufficiently protected by the standard two-dose COVID-19 ...
S. Caillard, O. Thaunat
semanticscholar   +1 more source

Comparison of SARS-CoV-2 Antibody Response 4 Weeks After Homologous vs Heterologous Third Vaccine Dose in Kidney Transplant Recipients

open access: yesJAMA Internal Medicine, 2021
Key Points Question Does a heterologous SARS-CoV-2 vaccination strategy with the vector vaccine Ad26COVS1 result in a higher rate of antibody response compared with a homologous third dose of mRNA vaccine (mRNA-1273 or BNT162b2) in kidney transplant ...
R. Reindl-Schwaighofer   +28 more
semanticscholar   +1 more source

European Guideline for the Management of Kidney Transplant Patients With HLA Antibodies: By the European Society for Organ Transplantation Working Group

open access: yesTransplant International, 2022
This guideline, from a European Society of Organ Transplantation (ESOT) working group, concerns the management of kidney transplant patients with HLA antibodies.
N. Mamode   +7 more
semanticscholar   +1 more source

COVID-19 in kidney transplant recipients

open access: yesAmerican Journal of Transplantation, 2020
There is minimal information on coronavirus disease 2019 (COVID‐19) in immunocompromised individuals. We have studied 10 patients treated at 12 adult care hospitals.
Vinay Nair   +15 more
semanticscholar   +2 more sources

COVID-19-related mortality in kidney transplant and dialysis patients: results of the ERACODA collaboration

open access: yesNephrology, Dialysis and Transplantation, 2020
Background. Patients on kidney replacement therapy comprise a vulnerable population and may be at increased risk of death from coronavirus disease 2019 (COVID-19). Currently, only limited data are available on outcomes in this patient population. Methods.
L. Hilbrands   +186 more
semanticscholar   +1 more source

Survival Benefit of First Single-Organ Deceased Donor Kidney Transplantation Compared With Long-term Dialysis Across Ages in Transplant-Eligible Patients With Kidney Failure

open access: yesJAMA Network Open, 2022
Key Points Question What is the difference in 10-year restricted mean survival time when receiving a kidney transplant versus remaining on the wait list and continuing dialysis for transplant-eligible patients with kidney failure across different ages ...
S. Strohmaier   +6 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy